Advanced Filter

Filter by Group

Filter by Market Availability

Displaying drugs 11601 - 11625 of 12763 in total
Indalpine was one of the first selective serotonin reuptake inhibitors to reach the American market. It was initially marketed by Pharmuka. However, after the emergence of widespread concern regarding adverse effects caused by SSRIs, and reported hematological effects caused by Indalpine, it was abruptly withdrawn from the US market.
Investigational
Withdrawn
Matched Iupac: … 3-[2-(piperidin-4-yl)ethyl]-1H-indole …
L-NAME has been investigated for the treatment of Hypotension and Spinal Cord Injury.
Investigational
Matched Iupac: … methyl (2S)-2-amino-5-(N'-nitrocarbamimidamido)pentanoate …
Experimental
Matched Iupac: … 3-[2-(diethylamino)ethyl]-3-phenylpiperidine-2,6-dione …
Experimental
Matched Iupac: … 4-[1-hydroxy-2-(methylamino)ethyl]-2,6-dimethoxyphenol …
Experimental
Matched Iupac: … 3-(2,2,2-trimethylhydrazin-2-ium-1-yl)propanoate …
Experimental
Matched Iupac: … {2-[1-(4-chlorophenyl)-1-phenylethoxy]propyl}dimethylamine …
Experimental
Matched Iupac: … (1R,4S)-1,3,3-trimethylbicyclo[2.2.1]heptan-2-one …
Investigational
Matched Iupac: … 1-(2-hydroxy-4-methoxyphenyl)ethan-1-one …
6-diazo-5-oxo-L-norleucine is a broad-acting glutamine antagonist.
Investigational
Matched Iupac: … (2S)-2-amino-6-diazo-5-oxohexanoic acid …
Fencamfamin (Glucoenergan, Reactivan) is a stimulant which was developed in the 1960s as an appetite suppressant, but was later withdrawn for this application due to problems with dependence and abuse. It is around half the potency of dexamphetamine, and is prescribed at a dose of 10-60mg, although abusers of the...
Experimental
Illicit
Withdrawn
Matched Iupac: … N-ethyl-3-phenylbicyclo[2.2.1]heptan-2-amine …
Experimental
Matched Iupac: … (2R)-2-amino-3-[(hydroxyarsanyl)sulfanyl]propanoic acid …
Experimental
Matched Iupac: … 4-[3-(dimethylamino)propoxy]-2H-thiochromen-2-one …
Experimental
Matched Iupac: … (2S)-2-amino-3-[(methylmercurio)sulfanyl]propanoic acid …
Experimental
Matched Iupac: … (2S)-2-amino-4-(carboxymethoxy)-4-oxobutanoic acid …
Experimental
Matched Iupac: … (2S)-2-amino-3-(4-iodophenyl)propanoic acid …
Experimental
Matched Iupac: … (2S)-2-amino-4-[(trifluoromethyl)sulfanyl]butanoic acid …
Experimental
Matched Iupac: … (2S)-2-amino-4-[(difluoromethyl)sulfanyl]butanoic acid …
Experimental
Matched Iupac: … (2R)-2-amino-3-[(dimethylarsanyl)sulfanyl]propanoic acid …
An inhibitor of nitric oxide synthetase which has been shown to prevent glutamate toxicity. Nitroarginine has been experimentally tested for its ability to prevent ammonia toxicity and ammonia-induced alterations in brain energy and ammonia metabolites. (Neurochem Res 1995:200(4):451-6)
Experimental
Investigational
Matched Iupac: … (2S)-2-amino-5-(N'-nitrocarbamimidamido)pentanoic acid …
Experimental
Matched Iupac: … 3-amino-3-(2-hydroxyethyl)pentane-1,5-diol …
Experimental
Matched Iupac: … (2R)-2-(3-carboxypropanamido)-4-(methylsulfanyl)butanoic acid …
EpiCept NP-1 is a prescription topical analgesic cream designed to provide effective, long-term relief from the pain of peripheral neuropathies. Peripheral neuropathies are medical conditions caused by damage to the nerves in the peripheral nervous system. The peripheral nervous system includes nerves that run from the brain and spinal cord...
Investigational
Matched Iupac: … N1-(4-methyl-2-nitrophenyl)propane-1,3-diamine …
Experimental
Matched Iupac: … (2S)-2-amino-3-(naphthalen-1-yl)propanamide …
Acediasulfone (INN) is an antimicrobial and antimalarial long-acting prodrug of dapsone.
Experimental
Matched Iupac: … 2-{[4-(4-aminobenzenesulfonyl)phenyl]amino}acetic acid …
Pyridoxamine has been used in trials studying the treatment of Kidney Stones.
Investigational
Matched Iupac: … 4-(aminomethyl)-5-(hydroxymethyl)-2-methylpyridin-3-ol …
Displaying drugs 11601 - 11625 of 12763 in total